/
BNTC
$12.56+$0.22 (+1.78%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$423.9M
34M shares
52-week range
$9.85 – $16.76
39% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Change$-53.74
Benitec Biopharma Inc. Common Stock
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
www.benitec.com- Employees
- 19
- IPO / List date
- Jul 11, 2012
- HQ
- HAYWARD, CA
Held by traders on TradeandTell
No one on the platform currently holds BNTC.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BNTC as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2023-07-26 | 1-for-17reverse |
Recent trades on TradeandTell
No one on the platform has traded BNTC yet.
